Symbols / APLM Stock $13.24 -1.85% Apollomics, Inc.
APLM (Stock) Chart
About
Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other solid tumors with MET dysregulation; APL-102, an oral active, small molecule multiple tyrosine kinase inhibitor, which is in a in a Phase 1 clinical trial to inhibit various kinases that are aberrantly activated in cancer cells; and APL-122, a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways that is in Phase 1 dose escalation clinical trials to treat cancers within the brain. Its immuno-oncology product candidates comprise APL-501, APL-502, and APL-801. The company was founded in 2015 and is based in Foster City, California.
Stock Fundamentals
Scroll to Statements| Market Cap | 28.43M | Enterprise Value | 13.53M | Income | -31.19M | Sales | 6.93M | Book/sh | -3.99 | Cash/sh | 1.90 |
| Dividend Yield | — | Payout | 0.00% | Employees | 13 | IPO | — | P/E | — | Forward P/E | -20.37 |
| PEG | — | P/S | 4.10 | P/B | -3.32 | P/C | — | EV/EBITDA | -0.51 | EV/Sales | 1.95 |
| Quick Ratio | 0.91 | Current Ratio | 0.97 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -26.64 | EPS next Y | -0.65 |
| EPS Growth | — | Revenue Growth | 3.81% | Earnings | — | ROA | -72.29% | ROE | -3.80% | ROIC | — |
| Gross Margin | 100.00% | Oper. Margin | -124.80% | Profit Margin | 0.00% | Shs Outstand | 2.15M | Shs Float | 583.97K | Short Float | 0.45% |
| Short Ratio | 1.62 | Short Interest | — | 52W High | 42.12 | 52W Low | 3.66 | Beta | 1.83 | Avg Volume | 9.69K |
| Volume | 1.38K | Target Price | — | Recom | None | Prev Close | $13.49 | Price | $13.24 | Change | -1.85% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$13.24
Latest analyst target
3. DCF / Fair value
$-121.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$13.24
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-05-08 | main | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-04-01 | main | EF Hutton | Buy → Buy | $7 |
| 2024-04-01 | main | HC Wainwright & Co. | Buy → Buy | $5 |
| 2023-11-20 | reit | HC Wainwright & Co. | Buy → Buy | $17 |
| 2023-10-03 | main | HC Wainwright & Co. | Buy → Buy | $17 |
| 2023-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $18 |
| 2023-06-01 | init | HC Wainwright & Co. | — → Buy | $18 |
| 2023-04-25 | init | EF Hutton | — → Buy | $25 |
- APLM SEC Filings - APOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan Wed, 22 Apr 2026 02
- Apollomics (APLM) Stock: Is It a Smart Investment (Slight Loss) 2026-04-18 - Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai Sun, 19 Apr 2026 04
- What happens to Apollomics (APLM) Stock after earnings | Price at $15.10, Up 1.68% - Expert Breakout Alerts - UBND thành phố Hải Phòng Fri, 10 Apr 2026 07
- Apollomics (APLM) chair reports 41.8% stake and $2M convertible bridge loan - Stock Titan Mon, 06 Apr 2026 07
- Is Apollomics (APLM) Stock Safe to Buy Now | Price at $15.30, Up 4.44% - Upside Potential - Cổng thông tin điện tử Tỉnh Sơn La Wed, 08 Apr 2026 07
- Apollomics (APLM) director details RSUs, options and warrants in Form 3/A - Stock Titan Fri, 17 Apr 2026 23
- Apollomics (APLM) CFO has shares withheld for RSU tax obligations - Stock Titan Fri, 17 Apr 2026 23
- Apollomics (APLM) director discloses 1,000 restricted stock units award - Stock Titan ue, 14 Apr 2026 23
- Apollomics (APLM) director Jan Chen-Huan reports 1,000 RSUs and 1,000 shares - Stock Titan Wed, 15 Apr 2026 00
- Apollomics (APLM) CFO details 20,000 RSUs and 15,900 shares in Form 3/A - Stock Titan ue, 14 Apr 2026 23
- [Form 3/A] Apollomics Inc. Amended Initial Statement of Beneficial Ownership - Stock Titan Wed, 15 Apr 2026 00
- Apollomics (APLM) director Huang Ya-Chi details RSU vesting and share holdings - Stock Titan ue, 14 Apr 2026 23
- Apollomics (APLM) COO details RSU grants and Maxpro warrant stakes - Stock Titan ue, 14 Apr 2026 23
- Apollomics (ticker: APLM) CEO details direct and indirect share stakes - Stock Titan ue, 14 Apr 2026 07
- Biotech Apollomics gets $2M from its CEO to fund clinical programs - Stock Titan Wed, 01 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
42.03
-22.69%
|
54.37
+22.49%
|
44.39
-11.70%
|
50.27
|
| Research And Development |
|
24.57
-28.15%
|
34.19
-3.56%
|
35.46
-0.31%
|
35.57
|
| Selling General And Administration |
|
17.77
-13.92%
|
20.64
+107.51%
|
9.95
-34.95%
|
15.29
|
| General And Administrative Expense |
|
17.77
-13.92%
|
20.64
+107.51%
|
9.95
-34.95%
|
15.29
|
| Other Gand A |
|
17.77
-13.92%
|
20.64
+107.51%
|
9.95
-34.95%
|
15.29
|
| Other Operating Expenses |
|
-0.30
+35.13%
|
-0.46
+54.33%
|
-1.02
-73.08%
|
-0.59
|
| Total Expenses |
|
42.03
-22.69%
|
54.37
+22.49%
|
44.39
-11.70%
|
50.27
|
| Operating Income |
|
-42.03
+22.69%
|
-54.37
-22.49%
|
-44.39
+11.70%
|
-50.27
|
| EBITDA |
|
-53.06
+69.11%
|
-171.77
+28.41%
|
-239.94
-155.17%
|
-94.03
|
| Normalized EBITDA |
|
-40.40
+76.75%
|
-173.78
+27.42%
|
-239.44
-162.91%
|
-91.07
|
| Reconciled Depreciation |
|
0.36
-46.04%
|
0.67
-13.68%
|
0.78
+13.80%
|
0.68
|
| EBIT |
|
-53.42
+69.02%
|
-172.44
+28.36%
|
-240.72
-154.15%
|
-94.71
|
| Total Unusual Items |
|
-12.66
-729.08%
|
2.01
+497.63%
|
-0.51
+82.92%
|
-2.96
|
| Total Unusual Items Excluding Goodwill |
|
-12.66
-729.08%
|
2.01
+497.63%
|
-0.51
+82.92%
|
-2.96
|
| Special Income Charges |
|
-13.00
|
0.00
|
0.00
+100.00%
|
-3.00
|
| Impairment Of Capital Assets |
|
13.00
|
0.00
|
0.00
-100.00%
|
3.00
|
| Net Income |
|
-53.86
+68.80%
|
-172.60
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Pretax Income |
|
-53.60
+68.94%
|
-172.59
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Net Non Operating Interest Income Expense |
|
0.30
-50.08%
|
0.60
+78.40%
|
0.34
-11.98%
|
0.38
|
| Interest Expense Non Operating |
|
0.18
+19.33%
|
0.15
+61.29%
|
0.09
+12.05%
|
0.08
|
| Net Interest Income |
|
0.30
-50.08%
|
0.60
+78.40%
|
0.34
-11.98%
|
0.38
|
| Interest Expense |
|
0.18
+19.33%
|
0.15
+61.29%
|
0.09
+12.05%
|
0.08
|
| Interest Income Non Operating |
|
0.48
-36.25%
|
0.75
+74.71%
|
0.43
-7.71%
|
0.47
|
| Interest Income |
|
0.48
-36.25%
|
0.75
+74.71%
|
0.43
-7.71%
|
0.47
|
| Other Income Expense |
|
-11.87
+90.01%
|
-118.82
+39.61%
|
-196.76
-338.14%
|
-44.91
|
| Other Non Operating Income Expenses |
|
0.79
+100.65%
|
-120.84
+38.43%
|
-196.25
-367.87%
|
-41.95
|
| Gain On Sale Of Security |
|
0.34
-82.95%
|
2.01
+497.63%
|
-0.51
-1431.58%
|
0.04
|
| Tax Provision |
|
0.26
+2490.00%
|
0.01
+900.00%
|
0.00
+0.00%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
-22.22%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-2.66
-729.08%
|
0.42
+497.63%
|
-0.11
+86.71%
|
-0.80
|
| Net Income Including Noncontrolling Interests |
|
-53.86
+68.80%
|
-172.60
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Net Income From Continuing Operation Net Minority Interest |
|
-53.86
+68.80%
|
-172.60
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Net Income From Continuing And Discontinued Operation |
|
-53.86
+68.80%
|
-172.60
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Net Income Continuous Operations |
|
-53.86
+68.80%
|
-172.60
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Normalized Income |
|
-43.86
+74.82%
|
-174.19
+27.54%
|
-240.41
-159.53%
|
-92.63
|
| Net Income Common Stockholders |
|
-53.86
+68.80%
|
-172.60
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Diluted EPS |
|
—
|
-231.99
-7650.04%
|
-2.99
-154.03%
|
-1.18
|
| Basic EPS |
|
—
|
-231.99
-7650.04%
|
-2.99
-154.03%
|
-1.18
|
| Basic Average Shares |
|
—
|
0.74
-99.08%
|
80.45
+0.00%
|
80.45
|
| Diluted Average Shares |
|
—
|
0.74
-99.08%
|
80.45
+0.00%
|
80.45
|
| Diluted NI Availto Com Stockholders |
|
-53.86
+68.80%
|
-172.60
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
13.10
-76.35%
|
55.39
-27.58%
|
76.47
-38.05%
|
123.44
|
| Current Assets |
|
10.27
-74.28%
|
39.92
-28.44%
|
55.79
-43.86%
|
99.37
|
| Cash Cash Equivalents And Short Term Investments |
|
9.77
-74.18%
|
37.82
-30.76%
|
54.61
-42.20%
|
94.48
|
| Cash And Cash Equivalents |
|
9.77
-69.53%
|
32.06
-1.89%
|
32.67
-30.09%
|
46.74
|
| Other Short Term Investments |
|
0.00
-100.00%
|
5.76
-73.74%
|
21.94
-54.05%
|
47.74
|
| Receivables |
|
0.13
-72.75%
|
0.47
-14.81%
|
0.55
+8.10%
|
0.51
|
| Taxes Receivable |
|
0.13
-72.75%
|
0.47
-14.81%
|
0.55
+8.10%
|
0.51
|
| Prepaid Assets |
|
0.37
-77.22%
|
1.64
+161.05%
|
0.63
-70.37%
|
2.12
|
| Current Deferred Assets |
|
—
|
—
|
0.00
-100.00%
|
2.25
|
| Total Non Current Assets |
|
2.83
-81.69%
|
15.46
-25.25%
|
20.68
-14.06%
|
24.07
|
| Net PPE |
|
1.02
+73.89%
|
0.59
-60.30%
|
1.48
+12.16%
|
1.32
|
| Gross PPE |
|
1.51
-52.31%
|
3.16
-17.86%
|
3.85
+28.83%
|
2.99
|
| Accumulated Depreciation |
|
-0.49
+80.99%
|
-2.58
-8.50%
|
-2.38
-41.94%
|
-1.67
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.98
-61.85%
|
2.57
-10.16%
|
2.87
+21.04%
|
2.37
|
| Machinery Furniture Equipment |
|
0.40
-11.43%
|
0.46
-46.60%
|
0.85
+74.59%
|
0.49
|
| Leases |
|
0.12
-8.15%
|
0.14
+0.00%
|
0.14
+0.00%
|
0.14
|
| Goodwill And Other Intangible Assets |
|
1.74
-88.23%
|
14.76
-0.14%
|
14.78
-0.14%
|
14.80
|
| Other Intangible Assets |
|
1.74
-88.23%
|
14.76
-0.14%
|
14.78
-0.14%
|
14.80
|
| Investments And Advances |
|
—
|
0.00
-100.00%
|
4.31
-45.08%
|
7.84
|
| Other Investments |
|
—
|
0.00
-100.00%
|
4.31
-45.08%
|
7.84
|
| Non Current Prepaid Assets |
|
0.07
-36.97%
|
0.12
-4.03%
|
0.12
+9.73%
|
0.11
|
| Total Liabilities Net Minority Interest |
|
8.23
-41.82%
|
14.15
-97.30%
|
524.60
+55.99%
|
336.30
|
| Current Liabilities |
|
7.40
-45.42%
|
13.56
+9.70%
|
12.36
-8.84%
|
13.56
|
| Payables And Accrued Expenses |
|
7.17
-21.79%
|
9.16
-21.52%
|
11.68
+2.40%
|
11.40
|
| Payables |
|
1.25
-79.10%
|
5.97
-20.79%
|
7.54
+25.49%
|
6.01
|
| Other Payable |
|
1.25
-79.10%
|
5.97
-20.79%
|
7.54
+25.49%
|
6.01
|
| Current Accrued Expenses |
|
5.92
+85.46%
|
3.19
-22.87%
|
4.14
-23.30%
|
5.39
|
| Total Tax Payable |
|
—
|
—
|
—
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.23
-94.70%
|
4.39
+615.64%
|
0.61
+20.87%
|
0.51
|
| Current Debt |
|
—
|
4.24
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.23
+47.47%
|
0.16
-74.27%
|
0.61
+20.87%
|
0.51
|
| Current Deferred Liabilities |
|
—
|
—
|
1.00
+0.00%
|
1.00
|
| Other Current Liabilities |
|
—
|
—
|
0.07
-95.87%
|
1.65
|
| Total Non Current Liabilities Net Minority Interest |
|
0.83
+39.87%
|
0.60
-99.88%
|
512.24
+58.71%
|
322.74
|
| Long Term Debt And Capital Lease Obligation |
|
0.73
+174.53%
|
0.27
-29.18%
|
0.38
-28.60%
|
0.53
|
| Long Term Capital Lease Obligation |
|
0.73
+174.53%
|
0.27
-29.18%
|
0.38
-28.60%
|
0.53
|
| Other Non Current Liabilities |
|
—
|
—
|
511.86
+58.86%
|
322.21
|
| Preferred Securities Outside Stock Equity |
|
—
|
0.00
-100.00%
|
511.86
+58.86%
|
322.21
|
| Stockholders Equity |
|
4.86
-88.20%
|
41.23
+109.20%
|
-448.12
-110.52%
|
-212.86
|
| Common Stock Equity |
|
4.86
-88.20%
|
41.23
+109.20%
|
-448.12
-110.52%
|
-212.86
|
| Capital Stock |
|
0.01
+22.22%
|
0.01
-78.05%
|
0.04
+2.50%
|
0.04
|
| Common Stock |
|
0.01
+22.22%
|
0.01
-78.05%
|
0.04
+2.50%
|
0.04
|
| Share Issued |
|
1.10
+23.22%
|
0.89
-98.89%
|
80.45
+0.00%
|
80.45
|
| Ordinary Shares Number |
|
1.10
+23.22%
|
0.89
-98.89%
|
80.45
+0.00%
|
80.45
|
| Additional Paid In Capital |
|
666.53
+0.76%
|
661.47
+5287.03%
|
12.28
+3.29%
|
11.89
|
| Retained Earnings |
|
-700.82
-8.32%
|
-646.97
-36.32%
|
-474.60
-101.58%
|
-235.44
|
| Gains Losses Not Affecting Retained Earnings |
|
3.44
+0.00%
|
3.44
+1.09%
|
3.40
+39.26%
|
2.44
|
| Treasury Stock |
|
0.00
|
0.00
-100.00%
|
0.07
-95.87%
|
1.65
|
| Other Equity Adjustments |
|
3.44
+0.00%
|
3.44
+1.09%
|
3.40
+39.26%
|
2.44
|
| Total Equity Gross Minority Interest |
|
4.86
-88.20%
|
41.23
+109.20%
|
-448.12
-110.52%
|
-212.86
|
| Total Capitalization |
|
4.86
-88.20%
|
41.23
+109.20%
|
-448.12
-110.52%
|
-212.86
|
| Working Capital |
|
2.87
-89.12%
|
26.37
-39.29%
|
43.43
-49.39%
|
85.81
|
| Invested Capital |
|
4.86
-89.30%
|
45.47
+110.15%
|
-448.12
-110.52%
|
-212.86
|
| Total Debt |
|
0.97
-79.27%
|
4.66
+370.33%
|
0.99
-4.34%
|
1.04
|
| Capital Lease Obligations |
|
0.97
+127.29%
|
0.42
-57.11%
|
0.99
-4.34%
|
1.04
|
| Net Tangible Assets |
|
3.13
-88.19%
|
26.48
+105.72%
|
-462.90
-103.33%
|
-227.66
|
| Tangible Book Value |
|
3.13
-88.19%
|
26.48
+105.72%
|
-462.90
-103.33%
|
-227.66
|
| Derivative Product Liabilities |
|
0.10
-69.09%
|
0.33
|
0.00
|
—
|
| Line Of Credit |
|
0.00
-100.00%
|
4.24
|
0.00
|
—
|
| Other Equity Interest |
|
35.71
+53.40%
|
23.28
+114.97%
|
10.83
+9.93%
|
9.85
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-28.74
+33.48%
|
-43.21
-0.90%
|
-42.82
+1.13%
|
-43.31
|
| Cash Flow From Continuing Operating Activities |
|
-28.74
+33.48%
|
-43.21
-0.90%
|
-42.82
+1.13%
|
-43.31
|
| Net Income From Continuing Operations |
|
-53.60
+68.94%
|
-172.59
+28.33%
|
-240.81
-154.03%
|
-94.80
|
| Depreciation Amortization Depletion |
|
0.36
-46.04%
|
0.67
-13.68%
|
0.78
+13.80%
|
0.68
|
| Depreciation |
|
0.34
-47.46%
|
0.65
-14.04%
|
0.76
+14.22%
|
0.66
|
| Amortization Cash Flow |
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
|
| Depreciation And Amortization |
|
0.36
-46.04%
|
0.67
-13.68%
|
0.78
+13.80%
|
0.68
|
| Amortization Of Intangibles |
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
|
| Other Non Cash Items |
|
-0.01
-100.01%
|
44.83
+13361.83%
|
-0.34
+11.98%
|
-0.38
|
| Stock Based Compensation |
|
10.93
-13.87%
|
12.69
+254.13%
|
3.58
-55.90%
|
8.12
|
| Asset Impairment Charge |
|
13.00
|
0.00
|
0.00
-100.00%
|
3.00
|
| Operating Gains Losses |
|
0.02
+133.96%
|
-0.05
+97.21%
|
-1.90
|
—
|
| Gain Loss On Investment Securities |
|
—
|
0.04
|
—
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
-0.22
-100.30%
|
74.83
-60.47%
|
189.32
+405.91%
|
37.42
|
| Net Foreign Currency Exchange Gain Loss |
|
0.00
+100.00%
|
-0.28
+85.32%
|
-1.90
|
0.00
|
| Gain Loss On Sale Of PPE |
|
0.02
-90.43%
|
0.19
|
0.00
|
0.00
|
| Change In Working Capital |
|
1.04
+129.07%
|
-3.57
-154.98%
|
6.49
+145.48%
|
2.64
|
| Change In Prepaid Assets |
|
1.61
+272.53%
|
-0.93
-125.53%
|
3.65
+905.96%
|
-0.45
|
| Change In Payables And Accrued Expense |
|
-0.57
+78.33%
|
-2.63
-192.88%
|
2.84
-8.37%
|
3.10
|
| Change In Payable |
|
-0.57
+78.33%
|
-2.63
-192.88%
|
2.84
-8.37%
|
3.10
|
| Investing Cash Flow |
|
5.98
-72.00%
|
21.36
-26.46%
|
29.05
+174.59%
|
-38.95
|
| Cash Flow From Continuing Investing Activities |
|
5.98
-72.00%
|
21.36
-26.46%
|
29.05
+174.59%
|
-38.95
|
| Net PPE Purchase And Sale |
|
-0.02
-138.46%
|
0.05
+114.17%
|
-0.37
-634.00%
|
-0.05
|
| Purchase Of PPE |
|
-0.02
-300.00%
|
-0.01
+98.37%
|
-0.37
-634.00%
|
-0.05
|
| Sale Of PPE |
|
0.00
-93.10%
|
0.06
|
0.00
|
0.00
|
| Capital Expenditure |
|
-0.02
-300.00%
|
-0.01
+98.37%
|
-0.37
+95.14%
|
-7.55
|
| Net Investment Purchase And Sale |
|
5.76
-71.88%
|
20.49
-29.36%
|
29.00
+191.07%
|
-31.84
|
| Purchase Of Investment |
|
—
|
—
|
0.00
+100.00%
|
-103.79
|
| Sale Of Investment |
|
5.76
-71.88%
|
20.49
-29.36%
|
29.00
-59.69%
|
71.95
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
|
0.00
+100.00%
|
-7.50
|
| Purchase Of Intangibles |
|
—
|
0.00
|
0.00
+100.00%
|
-7.50
|
| Net Other Investing Changes |
|
0.04
+780.00%
|
0.01
+145.45%
|
-0.01
+56.00%
|
-0.03
|
| Financing Cash Flow |
|
0.47
-97.80%
|
21.23
+7319.39%
|
-0.29
+82.11%
|
-1.64
|
| Cash Flow From Continuing Financing Activities |
|
0.47
-97.80%
|
21.23
+7319.39%
|
-0.29
+82.11%
|
-1.64
|
| Net Issuance Payments Of Debt |
|
0.66
-97.25%
|
24.04
+4154.13%
|
-0.59
-12.31%
|
-0.53
|
| Issuance Of Debt |
|
5.75
-76.51%
|
24.48
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-5.09
-1046.40%
|
-0.44
+25.13%
|
-0.59
-12.31%
|
-0.53
|
| Long Term Debt Issuance |
|
5.05
-75.07%
|
20.25
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-0.17
+61.71%
|
-0.44
+25.13%
|
-0.59
-12.31%
|
-0.53
|
| Net Long Term Debt Issuance |
|
4.88
-75.36%
|
19.80
+3439.80%
|
-0.59
-12.31%
|
-0.53
|
| Short Term Debt Issuance |
|
0.70
-83.43%
|
4.24
|
0.00
|
0.00
|
| Short Term Debt Payments |
|
-4.92
|
0.00
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
-4.22
-199.58%
|
4.24
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
—
|
—
|
0.39
+178.01%
|
0.14
|
| Cash Dividends Paid |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.09
-78.32%
|
0.39
+178.01%
|
0.14
|
| Net Other Financing Charges |
|
—
|
-2.78
|
—
|
-1.17
|
| Changes In Cash |
|
-22.29
-3501.29%
|
-0.62
+95.60%
|
-14.06
+83.24%
|
-83.91
|
| Effect Of Exchange Rate Changes |
|
0.00
|
0.00
|
0.00
|
—
|
| Beginning Cash Position |
|
32.06
-1.89%
|
32.67
-30.09%
|
46.74
-64.22%
|
130.65
|
| End Cash Position |
|
9.77
-69.53%
|
32.06
-1.89%
|
32.67
-30.09%
|
46.74
|
| Free Cash Flow |
|
-28.77
+33.43%
|
-43.22
-0.06%
|
-43.19
+15.08%
|
-50.86
|
| Common Stock Issuance |
|
—
|
—
|
0.39
+178.01%
|
0.14
|
| Interest Paid CFF |
|
-0.19
-58.20%
|
-0.12
-31.18%
|
-0.09
-12.05%
|
-0.08
|
| Interest Received CFI |
|
0.20
-75.88%
|
0.82
+90.49%
|
0.43
-7.71%
|
0.47
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.39
+178.01%
|
0.14
|
| Net Preferred Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Taxes Refund Paid |
|
-0.26
-2490.00%
|
-0.01
-117.86%
|
0.06
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-17 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|